{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:48:42Z","timestamp":1789145322600,"version":"build-2803163510"},"reference-count":238,"publisher":"Elsevier","isbn-type":[{"value":"9780323993944","type":"print"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["AA025590"],"award-info":[{"award-number":["AA025590"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["DA043172"],"award-info":[{"award-number":["DA043172"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["F32AA027962"],"award-info":[{"award-number":["F32AA027962"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/bs.irn.2022.10.004","type":"book-chapter","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T17:27:15Z","timestamp":1667842035000},"page":"367-413","source":"Crossref","is-referenced-by-count":4,"title":["Metabotropic glutamate receptors and cognition: From underlying plasticity and neuroprotection to cognitive disorders and therapeutic targets"],"prefix":"10.1016","member":"78","reference":[{"issue":"2","key":"10.1016\/bs.irn.2022.10.004_bb0010","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1021\/acsptsci.0c00013","article-title":"mGluR5 contribution to neuropathology in Alzheimer mice is disease stage-dependent","volume":"3","author":"Abd-Elrahman","year":"2020","journal-title":"ACS Pharmacology & Translational Science"},{"issue":"3","key":"10.1016\/bs.irn.2022.10.004_bb0015","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/6338","article-title":"Activation of NMDA receptors reverses desensitization of mGluR5 in native and recombinant systems","volume":"2","author":"Alagarsamy","year":"1999","journal-title":"Nature Neuroscience"},{"issue":"3","key":"10.1016\/bs.irn.2022.10.004_bb0020","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.nbd.2005.05.001","article-title":"Impaired metabotropic glutamate receptor\/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes","volume":"20","author":"Albasanz","year":"2005","journal-title":"Neurobiology of Disease"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb0025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neuroscience.2008.07.045","article-title":"A specific role for group II metabotropic glutamate receptors in hippocampal long-term depression and spatial memory","volume":"158","author":"Altinbilek","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/bs.irn.2022.10.004_bb0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.coph.2014.11.001","article-title":"Targeting metabotropic glutamate receptors (mGluRs) in Parkinson's disease","volume":"20","author":"Amalric","year":"2015","journal-title":"Current Opinion in Pharmacology"},{"issue":"7","key":"10.1016\/bs.irn.2022.10.004_bb0035","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.tins.2021.03.006","article-title":"Circuit organization of the rodent medial prefrontal cortex","volume":"44","author":"Anastasiades","year":"2021","journal-title":"Trends in Neurosciences"},{"issue":"7","key":"10.1016\/bs.irn.2022.10.004_bb0040","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1111\/j.1476-5381.2010.00820.x","article-title":"Symptomatic and neuroprotective effects following activation of nigral group III metabotropic glutamate receptors in rodent models of Parkinson's disease","volume":"160","author":"Austin","year":"2010","journal-title":"British Journal of Pharmacology"},{"issue":"21","key":"10.1016\/bs.irn.2022.10.004_bb0045","doi-asserted-by":"crossref","first-page":"7871","DOI":"10.1523\/JNEUROSCI.20-21-07871.2000","article-title":"Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus","volume":"20","author":"Awad","year":"2000","journal-title":"The Journal of Neuroscience"},{"issue":"9","key":"10.1016\/bs.irn.2022.10.004_bb0050","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/npp.2009.30","article-title":"mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning","volume":"34","author":"Ayala","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/bs.irn.2022.10.004_bb0055","article-title":"G-protein-coupled receptors in CNS: A potential therapeutic target for intervention in neurodegenerative disorders and associated cognitive deficits","volume":"9","author":"Azam","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/bs.irn.2022.10.004_bb0060","article-title":"Group I mGluRs in therapy and diagnosis of Parkinson's disease: Focus on mGluR5 subtype","volume":"10","author":"Azam","year":"2022","journal-title":"Biomedicine"},{"issue":"4","key":"10.1016\/bs.irn.2022.10.004_bb0065","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1080\/14640748608401616","article-title":"Dementia and working memory","volume":"38","author":"Baddeley","year":"1986","journal-title":"The Quarterly Journal of Experimental Psychology A"},{"issue":"1\u20134","key":"10.1016\/bs.irn.2022.10.004_bb0070","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000072845","article-title":"Understanding fragile X syndrome: insights from animal models","volume":"100","author":"Bakker","year":"2003","journal-title":"Cytogenetic and Genome Research"},{"issue":"2","key":"10.1016\/bs.irn.2022.10.004_bb0075","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0091-3057(02)00847-X","article-title":"Inhibition of mGluR5 blocks hippocampal LTP in vivo and spatial learning in rats","volume":"73","author":"Balschun","year":"2002","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"4","key":"10.1016\/bs.irn.2022.10.004_bb0080","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0168-0102(03)00002-6","article-title":"On long-term depression induced by activation of G-protein coupled receptors","volume":"45","author":"Bashir","year":"2003","journal-title":"Neuroscience Research"},{"issue":"6","key":"10.1016\/bs.irn.2022.10.004_bb0085","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1523\/JNEUROSCI.22-06-02135.2002","article-title":"Selective blockade of mGlu5 metabotropic glutamate receptors is protective against methamphetamine neurotoxicity","volume":"22","author":"Battaglia","year":"2002","journal-title":"The Journal of Neuroscience"},{"issue":"4","key":"10.1016\/bs.irn.2022.10.004_bb0090","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1523\/JNEUROSCI.3831-03.2004","article-title":"Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice","volume":"24","author":"Battaglia","year":"2004","journal-title":"The Journal of Neuroscience"},{"issue":"27","key":"10.1016\/bs.irn.2022.10.004_bb0095","doi-asserted-by":"crossref","first-page":"7222","DOI":"10.1523\/JNEUROSCI.1595-06.2006","article-title":"Pharmacological activation of mGlu4 metabotropic glutamate receptors reduces nigrostriatal degeneration in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"26","author":"Battaglia","year":"2006","journal-title":"The Journal of Neuroscience"},{"issue":"4","key":"10.1016\/bs.irn.2022.10.004_bb0100","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0896-6273(93)90086-7","article-title":"The metabotropic glutamate receptor (mGluR1 alpha) is concentrated at perisynaptic membrane of neuronal subpopulations as detected by immunogold reaction","volume":"11","author":"Baude","year":"1993","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/bs.irn.2022.10.004_bb0105","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1601-183X.2005.00135.x","article-title":"Therapeutic implications of the mGluR theory of fragile X mental retardation","volume":"4","author":"Bear","year":"2005","journal-title":"Genes, Brain, and Behavior"},{"issue":"4810","key":"10.1016\/bs.irn.2022.10.004_bb0110","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1126\/science.3037696","article-title":"A physiological basis for a theory of synapse modification","volume":"237","author":"Bear","year":"1987","journal-title":"Science"},{"issue":"7","key":"10.1016\/bs.irn.2022.10.004_bb0115","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.tins.2004.04.009","article-title":"The mGluR theory of fragile X mental retardation","volume":"27","author":"Bear","year":"2004","journal-title":"Trends in Neurosciences"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb0120","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1046\/j.1471-4159.2002.00815.x","article-title":"Functional and molecular characterization of metabotropic glutamate receptors expressed in rat striatal cholinergic interneurones","volume":"81","author":"Bell","year":"2002","journal-title":"Journal of Neurochemistry"},{"issue":"4","key":"10.1016\/bs.irn.2022.10.004_bb0125","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/jmg.2008.063701","article-title":"A pilot open label, single dose trial of fenobam in adults with fragile X syndrome","volume":"46","author":"Berry-Kravis","year":"2009","journal-title":"Journal of Medical Genetics"},{"issue":"13","key":"10.1016\/bs.irn.2022.10.004_bb0130","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1523\/JNEUROSCI.22-13-05403.2002","article-title":"Activation of group III metabotropic glutamate receptors inhibits the production of RANTES in glial cell cultures","volume":"22","author":"Besong","year":"2002","journal-title":"The Journal of Neuroscience"},{"issue":"8","key":"10.1016\/bs.irn.2022.10.004_bb0135","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1007\/s12035-019-1467-8","article-title":"Activation of mGluR1 mediates C1q-dependent microglial phagocytosis of glutamatergic synapses in Alzheimer's rodent models","volume":"56","author":"Bie","year":"2019","journal-title":"Molecular Neurobiology"},{"issue":"2","key":"10.1016\/bs.irn.2022.10.004_bb0140","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jecp.2009.01.002","article-title":"When simple things are meaningful: Working memory strength predicts children's cognitive flexibility","volume":"103","author":"Blackwell","year":"2009","journal-title":"Journal of Experimental Child Psychology"},{"issue":"17","key":"10.1016\/bs.irn.2022.10.004_bb0145","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1523\/JNEUROSCI.20-17-06413.2000","article-title":"Selective activation of mGlu4 metabotropic glutamate receptors is protective against excitotoxic neuronal death","volume":"20","author":"Bruno","year":"2000","journal-title":"The Journal of Neuroscience"},{"issue":"8","key":"10.1016\/bs.irn.2022.10.004_bb0150","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/0028-3908(95)00073-F","article-title":"The inhibitory mGluR agonist, S-4-carboxy-3-hydroxy-phenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death","volume":"34","author":"Buisson","year":"1995","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb0155","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1460-9568.1996.tb01174.x","article-title":"DCG-IV selectively attenuates rapidly triggered NMDA-induced neurotoxicity in cortical neurons","volume":"8","author":"Buisson","year":"1996","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2022.10.004_bb0160","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1100\/tsw.2002.146","article-title":"Altered short-term synaptic plasticity in mice lacking the metabotropic glutamate receptor mGlu7","volume":"2","author":"Bushell","year":"2002","journal-title":"ScientificWorldJournal"},{"issue":"3","key":"10.1016\/bs.irn.2022.10.004_bb0165","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00213-004-1827-5","article-title":"The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates PCP-induced cognitive deficits in rats","volume":"175","author":"Campbell","year":"2004","journal-title":"Psychopharmacology"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2022.10.004_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01248762","article-title":"The role of intraneuronal amine levels in the feedback control of dopamine, noradrenaline and 5-hydroxytryptamine synthesis in rat brain","volume":"39","author":"Carlsson","year":"1976","journal-title":"Journal of Neural Transmission"},{"issue":"3","key":"10.1016\/bs.irn.2022.10.004_bb0175","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1471-4159.2000.0750889.x","article-title":"Regulation of neurotransmitter release by metabotropic glutamate receptors","volume":"75","author":"Cartmell","year":"2000","journal-title":"Journal of Neurochemistry"},{"issue":"22","key":"10.1016\/bs.irn.2022.10.004_bb0180","doi-asserted-by":"crossref","first-page":"12772","DOI":"10.1073\/pnas.201404598","article-title":"A biophysical model of bidirectional synaptic plasticity: Dependence on AMPA and NMDA receptors","volume":"98","author":"Castellani","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1016\/bs.irn.2022.10.004_bb0185","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s11064-018-2476-0","article-title":"Disturbance of metabotropic glutamate receptor-mediated long-term depression (mGlu-LTD) of excitatory synaptic transmission in the rat hippocampus after prenatal immune challenge","volume":"44","author":"Cavalier","year":"2019","journal-title":"Neurochemical Research"},{"key":"10.1016\/bs.irn.2022.10.004_bb0190","article-title":"A polymorphism in the glutamate metabotropic receptor 7 is associated with cognitive deficits in the early phases of psychosis","author":"Chaumette","year":"2020","journal-title":"Schizophrenia Research"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb0195","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.schres.2004.07.002","article-title":"A case-control study of the relationship between the metabotropic glutamate receptor 3 gene and schizophrenia in the Chinese population","volume":"73","author":"Chen","year":"2005","journal-title":"Schizophrenia Research"},{"issue":"6","key":"10.1016\/bs.irn.2022.10.004_bb0200","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.neubiorev.2010.01.002","article-title":"Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: A decade of advance","volume":"34","author":"Cherlyn","year":"2010","journal-title":"Neuroscience and Biobehavioral Reviews"},{"issue":"10","key":"10.1016\/bs.irn.2022.10.004_bb0205","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1007\/s00213-018-4980-y","article-title":"Mutual activation of glutamatergic mGlu4 and muscarinic M4 receptors reverses schizophrenia-related changes in rodents","volume":"235","author":"Cie\u015blik","year":"2018","journal-title":"Psychopharmacology"},{"issue":"10","key":"10.1016\/bs.irn.2022.10.004_bb0210","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nrn1763","article-title":"Metabotropic glutamate receptors in the basal ganglia motor circuit","volume":"6","author":"Conn","year":"2005","journal-title":"Nature Reviews. Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb0215","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.tips.2008.10.006","article-title":"Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia","volume":"30","author":"Conn","year":"2009","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/bs.irn.2022.10.004_bb0220","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1146\/annurev.pharmtox.37.1.205","article-title":"Pharmacology and functions of metabotropic glutamate receptors","volume":"37","author":"Conn","year":"1997","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/bs.irn.2022.10.004_bb0225","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2014.12.031","article-title":"Neuronal activity patterns in the mediodorsal thalamus and related cognitive circuits are modulated by metabotropic glutamate receptors","volume":"92","author":"Copeland","year":"2015","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb0230","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11689-010-9067-y","article-title":"Clinical assessment of DSM-IV anxiety disorders in fragile X syndrome: Prevalence and characterization","volume":"3","author":"Cordeiro","year":"2011","journal-title":"Journal of Neurodevelopmental Disorders"},{"issue":"31","key":"10.1016\/bs.irn.2022.10.004_bb0235","doi-asserted-by":"crossref","first-page":"8297","DOI":"10.1523\/JNEUROSCI.1889-07.2007","article-title":"The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration\/neuroprotection","volume":"27","author":"Corti","year":"2007","journal-title":"The Journal of Neuroscience"},{"issue":"7","key":"10.1016\/bs.irn.2022.10.004_bb0240","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.biopsych.2006.12.005","article-title":"Altered dimerization of metabotropic glutamate receptor 3 in schizophrenia","volume":"62","author":"Corti","year":"2007","journal-title":"Biological Psychiatry"},{"key":"10.1016\/bs.irn.2022.10.004_bb0245","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.schres.2011.01.021","article-title":"Altered levels of glutamatergic receptors and Na+\/K+ ATPase-alpha1 in the prefrontal cortex of subjects with schizophrenia","volume":"128","author":"Corti","year":"2011","journal-title":"Schizophrenia Research"},{"issue":"4238","key":"10.1016\/bs.irn.2022.10.004_bb0250","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.3854","article-title":"Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs","volume":"192","author":"Creese","year":"1976","journal-title":"Science"},{"issue":"2","key":"10.1016\/bs.irn.2022.10.004_bb0255","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/sj.mp.4000966","article-title":"Comparative analysis of group II metabotropic glutamate receptor immunoreactivity in Brodmann's area 46 of the dorsolateral prefrontal cortex from patients with schizophrenia and normal subjects","volume":"7","author":"Crook","year":"2002","journal-title":"Molecular Psychiatry"},{"issue":"9","key":"10.1016\/bs.irn.2022.10.004_bb0260","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrd1825","article-title":"The ascent of mouse: Advances in modelling human depression and anxiety","volume":"4","author":"Cryan","year":"2005","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"15","key":"10.1016\/bs.irn.2022.10.004_bb0265","doi-asserted-by":"crossref","first-page":"5176","DOI":"10.1523\/JNEUROSCI.5351-09.2010","article-title":"Metabotropic glutamate receptor 1 mediates the electrophysiological and toxic actions of the cycad derivative beta-N-methylamino-L-alanine on substantia nigra pars compacta DAergic neurons","volume":"30","author":"Cucchiaroni","year":"2010","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2022.10.004_bb0270","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1192\/bjp.185.3.196","article-title":"Stimulant psychosis: Systematic review","volume":"185","author":"Curran","year":"2004","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/bs.irn.2022.10.004_bb0275","first-page":"10","article-title":"GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson's disease","volume":"9","author":"d'Anglemont de Tassigny","year":"2015","journal-title":"Frontiers in Neuroanatomy"},{"issue":"6","key":"10.1016\/bs.irn.2022.10.004_bb0280","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1073\/pnas.0609408104","article-title":"mGluR5 stimulates gliotransmission in the nucleus accumbens","volume":"104","author":"D'Ascenzo","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.irn.2022.10.004_bb0285","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pbb.2013.07.022","article-title":"Related functions of mGlu4 and mGlu8","volume":"111","author":"Davis","year":"2013","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb0290","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbr.2011.12.037","article-title":"Measures of anxiety, sensorimotor function, and memory in male and female mGluR4\u2212\/\u2212 mice","volume":"229","author":"Davis","year":"2012","journal-title":"Behavioural Brain Research"},{"issue":"11","key":"10.1016\/bs.irn.2022.10.004_bb0295","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1176\/ajp.148.11.1474","article-title":"Dopamine in schizophrenia: A review and reconceptualization","volume":"148","author":"Davis","year":"1991","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/bs.irn.2022.10.004_bb0300","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.neuropharm.2012.07.038","article-title":"Role of mGluR4 in acquisition of fear learning and memory","volume":"66","author":"Davis","year":"2013","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/bs.irn.2022.10.004_bb0305","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/npp.2008.129","article-title":"Metabotropic glutamate receptors 5 blockade reverses spatial memory deficits in a mouse model of Parkinson's disease","volume":"34","author":"De Leonibus","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.irn.2022.10.004_bb0310","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jad.2018.10.088","article-title":"Changes in levels of cortical metabotropic glutamate 2 receptors with gender and suicide but not psychiatric diagnoses","volume":"244","author":"Dean","year":"2019","journal-title":"Journal of Affective Disorders"},{"issue":"50","key":"10.1016\/bs.irn.2022.10.004_bb0315","doi-asserted-by":"crossref","first-page":"16922","DOI":"10.1523\/JNEUROSCI.3644-10.2010","article-title":"Projection-specific neuromodulation of medial prefrontal cortex neurons","volume":"30","author":"Dembrow","year":"2010","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2022.10.004_bb0320","series-title":"Cognitive deficits","author":"Dhakal","year":"2021"},{"issue":"5","key":"10.1016\/bs.irn.2022.10.004_bb0325","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1124\/molpharm.121.000460","article-title":"Metabotropic glutamate receptors as emerging targets for the treatment of schizophrenia","volume":"101","author":"Dogra","year":"2022","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/bs.irn.2022.10.004_bb0330","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/s12888-014-0351-3","article-title":"A double-blind, placebo-controlled comparator study of LY2140023 monohydrate in patients with schizophrenia","volume":"14","author":"Downing","year":"2014","journal-title":"BMC Psychiatry"},{"issue":"2","key":"10.1016\/bs.irn.2022.10.004_bb0335","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbr.2010.04.006","article-title":"Acute pharmacological modulation of mGluR8 reduces measures of anxiety","volume":"212","author":"Duvoisin","year":"2010","journal-title":"Behavioural Brain Research"},{"issue":"34","key":"10.1016\/bs.irn.2022.10.004_bb0340","doi-asserted-by":"crossref","first-page":"12604","DOI":"10.1073\/pnas.0405077101","article-title":"Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia","volume":"101","author":"Egan","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1016\/bs.irn.2022.10.004_bb0345","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0028-3908(03)00210-7","article-title":"ERKs regulate PKC-dependent synaptic depression and declustering of glutamate receptors in cerebellar Purkinje cells","volume":"45","author":"Endo","year":"2003","journal-title":"Neuropharmacology"},{"issue":"Pt 5","key":"10.1016\/bs.irn.2022.10.004_bb0350","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson's disease: Substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"issue":"10","key":"10.1016\/bs.irn.2022.10.004_bb0355","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/sj.mp.4002073","article-title":"mGluR7 facilitates extinction of aversive memories and controls amygdala plasticity","volume":"13","author":"Fendt","year":"2008","journal-title":"Molecular Psychiatry"},{"issue":"6","key":"10.1016\/bs.irn.2022.10.004_bb0360","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1046\/j.1460-9568.1999.00626.x","article-title":"Activation of the extracellular signal-regulated kinase 2 by metabotropic glutamate receptors","volume":"11","author":"Ferraguti","year":"1999","journal-title":"The European Journal of Neuroscience"},{"issue":"2","key":"10.1016\/bs.irn.2022.10.004_bb0365","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00441-006-0266-5","article-title":"Metabotropic glutamate receptors","volume":"326","author":"Ferraguti","year":"2006","journal-title":"Cell and Tissue Research"},{"issue":"45","key":"10.1016\/bs.irn.2022.10.004_bb0370","doi-asserted-by":"crossref","first-page":"10520","DOI":"10.1523\/JNEUROSCI.2547-05.2005","article-title":"Metabotropic glutamate receptor 8-expressing nerve terminals target subsets of GABAergic neurons in the hippocampus","volume":"25","author":"Ferraguti","year":"2005","journal-title":"The Journal of Neuroscience"},{"issue":"7","key":"10.1016\/bs.irn.2022.10.004_bb0375","doi-asserted-by":"crossref","DOI":"10.1111\/gbb.12654","article-title":"Phenotypic profiling of mGlu7 knockout mice reveals new implications for neurodevelopmental disorders","volume":"19","author":"Fisher","year":"2020","journal-title":"Genes, Brain, and Behavior"},{"issue":"4","key":"10.1016\/bs.irn.2022.10.004_bb0380","article-title":"A GRM7 mutation associated with developmental delay reduces mGlu7 expression and produces neurological phenotypes","volume":"6","author":"Fisher","year":"2021","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/bs.irn.2022.10.004_bb0385","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0028-3908(99)00123-9","article-title":"DHPG-induced LTD in area CA1 of juvenile rat hippocampus; characterisation and sensitivity to novel mGlu receptor antagonists","volume":"38","author":"Fitzjohn","year":"1999","journal-title":"Neuropharmacology"},{"issue":"22","key":"10.1016\/bs.irn.2022.10.004_bb0390","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.2174\/092986707781745550","article-title":"Noradrenaline in Parkinson's disease: From disease progression to current therapeutics","volume":"14","author":"Fornai","year":"2007","journal-title":"Current Medicinal Chemistry"},{"issue":"6","key":"10.1016\/bs.irn.2022.10.004_bb0395","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tins.2017.04.002","article-title":"Synaptic impairment in Alzheimer's disease: A dysregulated symphony","volume":"40","author":"Forner","year":"2017","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/bs.irn.2022.10.004_bb0400","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.nlm.2012.10.010","article-title":"Effects of a metabotropic glutamate receptor 5 positive allosteric modulator, CDPPB, on spatial learning task performance in rodents","volume":"99","author":"Fowler","year":"2013","journal-title":"Neurobiology of Learning and Memory"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2022.10.004_bb0405","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0926-6410(96)00054-7","article-title":"The role of the prefrontal cortex in higher cognitive functions","volume":"5","author":"Frith","year":"1996","journal-title":"Brain Research. Cognitive Brain Research"},{"issue":"5","key":"10.1016\/bs.irn.2022.10.004_bb0410","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci7050049","article-title":"Working memory in the prefrontal cortex","volume":"7","author":"Funahashi","year":"2017","journal-title":"Brain Sciences"},{"issue":"6","key":"10.1016\/bs.irn.2022.10.004_bb0415","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jphysparis.2013.05.001","article-title":"Prefrontal cortex and neural mechanisms of executive function","volume":"107","author":"Funahashi","year":"2013","journal-title":"Journal of Physiology, Paris"},{"issue":"12","key":"10.1016\/bs.irn.2022.10.004_bb0420","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1177\/0269881117715597","article-title":"A group II metabotropic glutamate receptor 3 (mGlu3, GRM3) isoform implicated in schizophrenia interacts with canonical mGlu3 and reduces ligand binding","volume":"31","author":"Garc\u00eda-Bea","year":"2017","journal-title":"Journal of Psychopharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb0425","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archneur.56.1.33","article-title":"Diagnostic criteria for Parkinson disease","volume":"56","author":"Gelb","year":"1999","journal-title":"Archives of Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2022.10.004_bb0430","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0028-3908(02)00078-3","article-title":"Performance deficits of mGluR8 knockout mice in learning tasks: The effects of null mutation and the background genotype","volume":"43","author":"Gerlai","year":"2002","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/bs.irn.2022.10.004_bb0435","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1176\/appi.ajp.2009.08091445","article-title":"Differential expression of metabotropic glutamate receptors 2 and 3 in schizophrenia: A mechanism for antipsychotic drug action?","volume":"166","author":"Ghose","year":"2009","journal-title":"The American Journal of Psychiatry"},{"issue":"7","key":"10.1016\/bs.irn.2022.10.004_bb0440","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/cercor\/bhm193","article-title":"Involvement of the mGluR1 receptor in hippocampal synaptic plasticity and associative learning in behaving mice","volume":"18","author":"Gil-Sanz","year":"2008","journal-title":"Cerebral Cortex"},{"issue":"403","key":"10.1016\/bs.irn.2022.10.004_bb0445","doi-asserted-by":"crossref","first-page":"eaai7459","DOI":"10.1126\/scitranslmed.aai7459","article-title":"mGlu7 potentiation rescues cognitive, social, and respiratory phenotypes in a mouse model of Rett syndrome","volume":"9","author":"Gogliotti","year":"2017","journal-title":"Science Translational Medicine"},{"issue":"3","key":"10.1016\/bs.irn.2022.10.004_bb0450","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0896-6273(95)90304-6","article-title":"Cellular basis of working memory","volume":"14","author":"Goldman-Rakic","year":"1995","journal-title":"Neuron"},{"issue":"7183","key":"10.1016\/bs.irn.2022.10.004_bb0455","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature06612","article-title":"Identification of a serotonin\/glutamate receptor complex implicated in psychosis","volume":"452","author":"Gonz\u00e1lez-Maeso","year":"2008","journal-title":"Nature"},{"issue":"4","key":"10.1016\/bs.irn.2022.10.004_bb0460","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/npp.2015.265","article-title":"Partial mGlu\u2085 negative allosteric modulators attenuate cocaine-mediated behaviors and lack psychotomimetic-like effects","volume":"41","author":"Gould","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/bs.irn.2022.10.004_bb0465","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/156802610790411018","article-title":"Metabotropic glutamate receptors as therapeutic targets for cognitive disorders","volume":"10","author":"Gravius","year":"2010","journal-title":"Current Topics in Medicinal Chemistry"},{"issue":"10 Suppl","key":"10.1016\/bs.irn.2022.10.004_bb0470","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/S1471-1931(00)00027-6","article-title":"Levodopa-induced dyskinesias and dopamine-dependent stereotypies: A new hypothesis","volume":"23","author":"Graybiel","year":"2000","journal-title":"Trends in Neurosciences"},{"issue":"2","key":"10.1016\/bs.irn.2022.10.004_bb0475","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0896-6273(00)00113-6","article-title":"Toward a neurobiology of obsessive-compulsive disorder","volume":"28","author":"Graybiel","year":"2000","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/bs.irn.2022.10.004_bb0480","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s00213-003-1444-8","article-title":"Anxiolytic effects of a novel group II metabotropic glutamate receptor agonist (LY354740) in the fear-potentiated startle paradigm in humans","volume":"168","author":"Grillon","year":"2003","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/bs.irn.2022.10.004_bb0485","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/sj.npp.1300672","article-title":"Group II and III metabotropic glutamate receptors suppress excitatory synaptic transmission in the dorsolateral bed nucleus of the stria terminalis","volume":"30","author":"Grueter","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/bs.irn.2022.10.004_bb0490","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/syn.20164","article-title":"Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia","volume":"57","author":"Gupta","year":"2005","journal-title":"Synapse"},{"issue":"9","key":"10.1016\/bs.irn.2022.10.004_bb0495","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.celrep.2016.04.077","article-title":"Chronic pharmacological mGluR5 inhibition prevents cognitive impairment and reduces pathogenesis in an Alzheimer disease mouse model","volume":"15","author":"Hamilton","year":"2016","journal-title":"Cell Reports"},{"issue":"2","key":"10.1016\/bs.irn.2022.10.004_bb0500","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neubiorev.2005.06.006","article-title":"The limbic lobe and its output channels: Implications for emotional functions and adaptive behavior","volume":"30","author":"Heimer","year":"2006","journal-title":"Neuroscience and Biobehavioral Reviews"},{"issue":"Pt 3","key":"10.1016\/bs.irn.2022.10.004_bb0505","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1042\/bj3590465","article-title":"Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: Prototypic family C G-protein-coupled receptors","volume":"359","author":"Hermans","year":"2001","journal-title":"The Biochemical Journal"},{"issue":"2","key":"10.1016\/bs.irn.2022.10.004_bb0510","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbr.2004.03.015","article-title":"Lack of the metabotropic glutamate receptor subtype 7 selectively impairs short-term working memory but not long-term memory","volume":"154","author":"H\u00f6lscher","year":"2004","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/bs.irn.2022.10.004_bb0515","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.700822","article-title":"Partial mGlu5 negative allosteric modulator M-5MPEP demonstrates antidepressant-like effects on sleep without affecting cognition or quantitative EEG","volume":"15","author":"Holter","year":"2021","journal-title":"Frontiers in Neuroscience"},{"issue":"1\u20133","key":"10.1016\/bs.irn.2022.10.004_bb0520","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejphar.2009.12.042","article-title":"Group 5 metabotropic glutamate receptors: Role in modulating cortical activity and relevance to cognition","volume":"639","author":"Homayoun","year":"2010","journal-title":"European Journal of Pharmacology"},{"issue":"7","key":"10.1016\/bs.irn.2022.10.004_bb0525","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/sj.npp.1300417","article-title":"Functional interaction between NMDA and mGlu5 receptors: Effects on working memory, instrumental learning, motor behaviors, and dopamine release","volume":"29","author":"Homayoun","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/bs.irn.2022.10.004_bb0530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035256","article-title":"Novel expression patterns of metabotropic glutamate receptor 6 in the zebrafish nervous system","volume":"7","author":"Huang","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/bs.irn.2022.10.004_bb0535","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.1073\/pnas.122205699","article-title":"Altered synaptic plasticity in a mouse model of fragile X mental retardation","volume":"99","author":"Huber","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1016\/bs.irn.2022.10.004_bb0540","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1053\/bega.2002.0356","article-title":"Evolving concepts in functional gastrointestinal disorders: Promising directions for novel pharmaceutical treatments","volume":"16","author":"Hunt","year":"2002","journal-title":"Best Practice & Research. Clinical Gastroenterology"},{"key":"10.1016\/bs.irn.2022.10.004_bb0545","doi-asserted-by":"crossref","first-page":"6212983","DOI":"10.1155\/2016\/6212983","article-title":"Social isolation stress induces anxious-depressive-like behavior and alterations of neuroplasticity-related genes in adult male mice","volume":"2016","author":"Ieraci","year":"2016","journal-title":"Neural Plasticity"},{"key":"10.1016\/bs.irn.2022.10.004_bb0550","article-title":"Unchanged type 1 metabotropic glutamate receptor availability in patients with Alzheimer's disease: A study using","volume":"22","author":"Ishibashi","year":"2019","journal-title":"Neuroimage: Clinical"},{"key":"10.1016\/bs.irn.2022.10.004_bb0555","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1146\/annurev.ne.12.030189.000505","article-title":"Long-term depression","volume":"12","author":"Ito","year":"1989","journal-title":"Annual Review of Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb0560","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2174\/1570159X14666160321123221","article-title":"Therapeutic modulation of glutamate receptors in major depressive disorder","volume":"15","author":"Jaso","year":"2017","journal-title":"Current Neuropharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb0565","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13024-018-0238-8","article-title":"Mfn2 ablation causes an oxidative stress response and eventual neuronal death in the hippocampus and cortex","volume":"13","author":"Jiang","year":"2018","journal-title":"Molecular Neurodegeneration"},{"issue":"6","key":"10.1016\/bs.irn.2022.10.004_bb0570","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2174\/187152709789824606","article-title":"Glutamate receptors as therapeutic targets for Parkinson's disease","volume":"8","author":"Johnson","year":"2009","journal-title":"CNS & Neurological Disorders Drug Targets"},{"issue":"22","key":"10.1016\/bs.irn.2022.10.004_bb0575","doi-asserted-by":"crossref","first-page":"14015","DOI":"10.1074\/jbc.273.22.14015","article-title":"Regulation of amyloid precursor protein secretion by glutamate receptors in human Ntera 2 neurons","volume":"273","author":"Jolly-Tornetta","year":"1998","journal-title":"The Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/bs.irn.2022.10.004_bb0580","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1124\/jpet.112.200915","article-title":"ADX71743, a potent and selective negative allosteric modulator of metabotropic glutamate receptor 7: In vitro and in vivo characterization","volume":"344","author":"Kalinichev","year":"2013","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"12","key":"10.1016\/bs.irn.2022.10.004_bb0585","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1111\/j.1460-9568.2005.04488.x","article-title":"Down-regulation of metabotropic glutamate receptor 1alpha in globus pallidus and substantia nigra of parkinsonian monkeys","volume":"22","author":"Kaneda","year":"2005","journal-title":"The European Journal of Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb0590","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1152\/jn.2001.86.1.280","article-title":"Induction of long-term depression in cerebellar Purkinje cells requires a rapidly turned over protein","volume":"86","author":"Karachot","year":"2001","journal-title":"Journal of Neurophysiology"},{"issue":"10","key":"10.1016\/bs.irn.2022.10.004_bb0595","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/cercor\/10.10.981","article-title":"Dendritic anomalies in disorders associated with mental retardation","volume":"10","author":"Kaufmann","year":"2000","journal-title":"Cerebral Cortex"},{"issue":"13","key":"10.1016\/bs.irn.2022.10.004_bb0600","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1038\/npp.2015.145","article-title":"mGluR2\/3 in the lateral amygdala is required for fear extinction: Cortical input synapses onto the lateral amygdala as a target site of the mGluR2\/3 action","volume":"40","author":"Kim","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.irn.2022.10.004_bb0605","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1749-6632.1999.tb08022.x","article-title":"Neuroprotective actions of novel and potent ligands of group I and group II metabotropic glutamate receptors","volume":"890","author":"Kingston","year":"1999","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb0610","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1124\/jpet.103.048702","article-title":"Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents","volume":"306","author":"Kinney","year":"2003","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"3","key":"10.1016\/bs.irn.2022.10.004_bb0615","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/JCP.0b013e318218dcd5","article-title":"A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia","volume":"31","author":"Kinon","year":"2011","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb0620","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00213-004-1982-8","article-title":"Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects","volume":"179","author":"Krystal","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.irn.2022.10.004_bb0625","first-page":"1830","article-title":"Alterations of mGluR1 in Parkinson's disease and suicide depression: An autoradiography study with [18F]MK1312","volume":"55","author":"Kumar","year":"2014","journal-title":"Journal of Nuclear Medicine"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb0630","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00213-014-3653-8","article-title":"mGluR5 positive allosteric modulation and its effects on MK-801 induced set-shifting impairments in a rat operant delayed matching\/non-matching-to-sample task","volume":"232","author":"LaCrosse","year":"2015","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/bs.irn.2022.10.004_bb0635","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/hmg\/10.4.329","article-title":"Evidence that fragile X mental retardation protein is a negative regulator of translation","volume":"10","author":"Laggerbauer","year":"2001","journal-title":"Human Molecular Genetics"},{"issue":"4","key":"10.1016\/bs.irn.2022.10.004_bb0640","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1460-9568.2009.06624.x","article-title":"Context conditioning and extinction in humans: Differential contribution of the hippocampus, amygdala and prefrontal cortex","volume":"29","author":"Lang","year":"2009","journal-title":"The European Journal of Neuroscience"},{"issue":"7","key":"10.1016\/bs.irn.2022.10.004_bb0645","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.biopsych.2006.12.003","article-title":"Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex","volume":"62","author":"Lecourtier","year":"2007","journal-title":"Biological Psychiatry"},{"key":"10.1016\/bs.irn.2022.10.004_bb0650","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev.neuro.23.1.155","article-title":"Emotion circuits in the brain","volume":"23","author":"LeDoux","year":"2000","journal-title":"Annual Review of Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb0655","doi-asserted-by":"crossref","first-page":"89","DOI":"10.55782\/ane-2004-1494","article-title":"The role of metabotropic glutamate receptors in Alzheimer's disease","volume":"64","author":"Lee","year":"2004","journal-title":"Acta Neurobiologiae Experimentalis (Wars)"},{"key":"10.1016\/bs.irn.2022.10.004_bb0660","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.brainres.2008.10.055","article-title":"The effect of mGluR2 activation on signal transduction pathways and neuronal cell survival","volume":"1249","author":"Lee","year":"2009","journal-title":"Brain Research"},{"issue":"4","key":"10.1016\/bs.irn.2022.10.004_bb0665","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF00216006","article-title":"Provocative tests with psychostimulant drugs in schizophrenia","volume":"91","author":"Lieberman","year":"1987","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/bs.irn.2022.10.004_bb0670","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1101\/lm.85304","article-title":"Activation of group II metabotropic glutamate receptors induces depotentiation in amygdala slices and reduces fear-potentiated startle in rats","volume":"12","author":"Lin","year":"2005","journal-title":"Learning & Memory"},{"key":"10.1016\/bs.irn.2022.10.004_bb0675","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fnins.2019.00043","article-title":"The role of NMDA receptors in Alzheimer's disease","volume":"13","author":"Liu","year":"2019","journal-title":"Frontiers in Neuroscience"},{"issue":"9","key":"10.1016\/bs.irn.2022.10.004_bb0680","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1523\/JNEUROSCI.20-09-03200.2000","article-title":"Agonist- and reflex-evoked internalization of metabotropic glutamate receptor 5 in enteric neurons","volume":"20","author":"Liu","year":"2000","journal-title":"The Journal of Neuroscience"},{"issue":"3","key":"10.1016\/bs.irn.2022.10.004_bb0685","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1124\/jpet.108.136580","article-title":"ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: A novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activities","volume":"327","author":"Liu","year":"2008","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"13","key":"10.1016\/bs.irn.2022.10.004_bb0690","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.1523\/JNEUROSCI.17-13-05196.1997","article-title":"Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP","volume":"17","author":"Lu","year":"1997","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2022.10.004_bb0695","doi-asserted-by":"crossref","DOI":"10.1038\/s41386-022-01350-0","article-title":"mGlu1-mediated restoration of prefrontal cortex inhibitory signaling reverses social and cognitive deficits in an NMDA hypofunction model in mice","author":"Luessen","year":"2022","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/bs.irn.2022.10.004_bb0700","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/j.1460-9568.1996.tb01611.x","article-title":"Perisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampus","volume":"8","author":"Lujan","year":"1996","journal-title":"The European Journal of Neuroscience"},{"issue":"7","key":"10.1016\/bs.irn.2022.10.004_bb0705","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5498\/wjp.v11.i7.277","article-title":"Novel approaches in schizophrenia-from risk factors and hypotheses to novel drug targets","volume":"11","author":"\u013dupt\u00e1k","year":"2021","journal-title":"World Journal of Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb0710","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1152\/physrev.00014.2003","article-title":"Long-term potentiation and memory","volume":"84","author":"Lynch","year":"2004","journal-title":"Physiological Reviews"},{"issue":"11","key":"10.1016\/bs.irn.2022.10.004_bb0715","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/syn.20553","article-title":"Altered hippocampal expression of glutamate receptors and transporters in GRM2 and GRM3 knockout mice","volume":"62","author":"Lyon","year":"2008","journal-title":"Synapse"},{"issue":"13","key":"10.1016\/bs.irn.2022.10.004_bb0720","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1038\/npp.2011.145","article-title":"Fractionation of spatial memory in GRM2\/3 (mGlu2\/mGlu3) double knockout mice reveals a role for group II metabotropic glutamate receptors at the interface between arousal and cognition","volume":"36","author":"Lyon","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb0725","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.tins.2011.06.007","article-title":"Fear conditioning, synaptic plasticity and the amygdala: Implications for posttraumatic stress disorder","volume":"35","author":"Mahan","year":"2012","journal-title":"Trends in Neurosciences"},{"issue":"5","key":"10.1016\/bs.irn.2022.10.004_bb0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109950","article-title":"mGlu1 potentiation enhances prelimbic somatostatin interneuron activity to rescue schizophrenia-like physiological and cognitive deficits","volume":"37","author":"Maksymetz","year":"2021","journal-title":"Cell Reports"},{"issue":"12","key":"10.1016\/bs.irn.2022.10.004_bb0735","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0166-2236(93)90197-T","article-title":"NMDA-receptor-dependent synaptic plasticity: Multiple forms and mechanisms","volume":"16","author":"Malenka","year":"1993","journal-title":"Trends in Neurosciences"},{"issue":"11","key":"10.1016\/bs.irn.2022.10.004_bb0740","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nrn1535","article-title":"Neuronal signalling of fear memory","volume":"5","author":"Maren","year":"2004","journal-title":"Nature Reviews. Neuroscience"},{"issue":"18","key":"10.1016\/bs.irn.2022.10.004_bb0745","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.1523\/JNEUROSCI.21-18-07001.2001","article-title":"Activation of group I metabotropic glutamate receptors produces a direct excitation and disinhibition of GABAergic projection neurons in the substantia nigra pars reticulata","volume":"21","author":"Marino","year":"2001","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2022.10.004_bb0750","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbr.2017.10.007","article-title":"ADX-47273, a mGlu5 receptor positive allosteric modulator, attenuates deficits in cognitive flexibility induced by withdrawal from 'binge-like' ethanol exposure in rats","volume":"338","author":"Marszalek-Grabska","year":"2018","journal-title":"Behavioural Brain Research"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb0755","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/ajmg.1624","article-title":"Metabotropic glutamate receptor 3 (GRM3) gene variation is not associated with schizophrenia or bipolar affective disorder in the German population","volume":"114","author":"Mart\u00ed","year":"2002","journal-title":"American Journal of Medical Genetics"},{"issue":"2","key":"10.1016\/bs.irn.2022.10.004_bb0760","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0896-6273(92)90165-A","article-title":"Cellular localization of a metabotropic glutamate receptor in rat brain","volume":"9","author":"Martin","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/bs.irn.2022.10.004_bb0765","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.coph.2018.03.004","article-title":"Metabotropic glutamate receptors: Targets for neuroprotective therapies in Parkinson disease","volume":"38","author":"Masilamoni","year":"2018","journal-title":"Current Opinion in Pharmacology"},{"issue":"Pt 7","key":"10.1016\/bs.irn.2022.10.004_bb0770","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1093\/brain\/awr137","article-title":"Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys","volume":"134","author":"Masilamoni","year":"2011","journal-title":"Brain"},{"key":"10.1016\/bs.irn.2022.10.004_bb0775","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neuropharm.2015.08.003","article-title":"Shifting towards a model of mGluR5 dysregulation in schizophrenia: Consequences for future schizophrenia treatment","volume":"115","author":"Matosin","year":"2017","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb0780","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00401-015-1411-6","article-title":"Alterations of mGluR5 and its endogenous regulators Norbin, Tamalin and Preso1 in schizophrenia: Towards a model of mGluR5 dysregulation","volume":"130","author":"Matosin","year":"2015","journal-title":"Acta Neuropathologica"},{"issue":"2","key":"10.1016\/bs.irn.2022.10.004_bb0785","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11682-017-9712-0","article-title":"Effects of common GRM5 genetic variants on cognition, hippocampal volume and mGluR5 protein levels in schizophrenia","volume":"12","author":"Matosin","year":"2018","journal-title":"Brain Imaging and Behavior"},{"key":"10.1016\/bs.irn.2022.10.004_bb0790","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1146\/annurev.genet.36.062802.091007","article-title":"Genetic approaches to molecular and cellular cognition: A focus on LTP and learning and memory","volume":"36","author":"Matynia","year":"2002","journal-title":"Annual Review of Genetics"},{"issue":"21","key":"10.1016\/bs.irn.2022.10.004_bb0795","doi-asserted-by":"crossref","first-page":"12683","DOI":"10.1073\/pnas.95.21.12683","article-title":"Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice","volume":"95","author":"Meziane","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"12","key":"10.1016\/bs.irn.2022.10.004_bb0800","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/mp.2012.47","article-title":"Pharmacological treatment of schizophrenia: A critical review of the pharmacology and clinical effects of current and future therapeutic agents","volume":"17","author":"Miyamoto","year":"2012","journal-title":"Molecular Psychiatry"},{"issue":"5381","key":"10.1016\/bs.irn.2022.10.004_bb0805","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1126\/science.281.5381.1349","article-title":"Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats","volume":"281","author":"Moghaddam","year":"1998","journal-title":"Science"},{"issue":"53","key":"10.1016\/bs.irn.2022.10.004_bb0810","doi-asserted-by":"crossref","first-page":"44301","DOI":"10.1074\/jbc.M112.413161","article-title":"Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A\u00b7mGlu2) receptor heteromerization and its psychoactive behavioral function","volume":"287","author":"Moreno","year":"2012","journal-title":"The Journal of Biological Chemistry"},{"issue":"410","key":"10.1016\/bs.irn.2022.10.004_bb0815","doi-asserted-by":"crossref","first-page":"ra5","DOI":"10.1126\/scisignal.aab0467","article-title":"Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia","volume":"9","author":"Moreno","year":"2016","journal-title":"Science Signaling"},{"issue":"2","key":"10.1016\/bs.irn.2022.10.004_bb0820","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00005072-199902000-00008","article-title":"Neurons may live for decades with neurofibrillary tangles","volume":"58","author":"Morsch","year":"1999","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"10.1016\/bs.irn.2022.10.004_bb0825","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2007.02.041","article-title":"Cellular localization of mGluR3 and mGluR5 mRNAs in normal and injured rat brain","volume":"1149","author":"Mudo","year":"2007","journal-title":"Brain Research"},{"key":"10.1016\/bs.irn.2022.10.004_bb0830","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fphar.2016.00130","article-title":"Group II metabotropic glutamate receptors as targets for novel antipsychotic drugs","volume":"7","author":"Muguruza","year":"2016","journal-title":"Frontiers in Pharmacology"},{"issue":"3","key":"10.1016\/bs.irn.2022.10.004_bb0835","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0304-3940(95)12248-6","article-title":"Pre- and postsynaptic localization of a metabotropic glutamate receptor, mGluR2, in the rat brain: An immunohistochemical study with a monoclonal antibody","volume":"202","author":"Neki","year":"1996","journal-title":"Neuroscience Letters"},{"issue":"16","key":"10.1016\/bs.irn.2022.10.004_bb0840","doi-asserted-by":"crossref","first-page":"6380","DOI":"10.1073\/pnas.0601267103","article-title":"mGluR2 acts through inhibitory Galpha subunits to regulate transmission and long-term plasticity at hippocampal mossy fiber-CA3 synapses","volume":"103","author":"Nicholls","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7\u20138","key":"10.1016\/bs.irn.2022.10.004_bb0845","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.neuropharm.2010.10.022","article-title":"Metabotropic glutamate receptors: From the workbench to the bedside","volume":"60","author":"Nicoletti","year":"2011","journal-title":"Neuropharmacology"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2022.10.004_bb0850","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/nlme.1998.3838","article-title":"NMDA receptor-dependent and metabotropic glutamate receptor-dependent forms of long-term depression coexist in CA1 hippocampal pyramidal cells","volume":"70","author":"Nicoll","year":"1998","journal-title":"Neurobiology of Learning and Memory"},{"key":"10.1016\/bs.irn.2022.10.004_bb0855","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","article-title":"Metabotropic glutamate receptors: Physiology, pharmacology, and disease","volume":"50","author":"Niswender","year":"2010","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"10 Suppl","key":"10.1016\/bs.irn.2022.10.004_bb0860","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S1471-1931(00)00031-8","article-title":"Levodopa motor complications in Parkinson's disease","volume":"23","author":"Obeso","year":"2000","journal-title":"Trends in Neurosciences"},{"issue":"1\u20133","key":"10.1016\/bs.irn.2022.10.004_bb0865","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejphar.2010.02.059","article-title":"Metabotropic glutamate receptor 7: At the interface of cognition and emotion","volume":"639","author":"O'Connor","year":"2010","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2022.10.004_bb0870","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev.neuro.25.112701.142909","article-title":"A decade of molecular studies of fragile X syndrome","volume":"25","author":"O'Donnell","year":"2002","journal-title":"Annual Review of Neuroscience"},{"key":"10.1016\/bs.irn.2022.10.004_bb0875","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1097\/00001756-200009280-00019","article-title":"Gene expression of PSD95 in prefrontal cortex and hippocampus in schizophrenia","volume":"11","author":"Ohnuma","year":"2000","journal-title":"Neuroreport"},{"issue":"6","key":"10.1016\/bs.irn.2022.10.004_bb0880","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0896-6273(00)80336-0","article-title":"Two distinct forms of long-term depression coexist in CA1 hippocampal pyramidal cells","volume":"18","author":"Oliet","year":"1997","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/bs.irn.2022.10.004_bb0885","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.tics.2018.12.006","article-title":"Dopamine and cognitive control in prefrontal cortex","volume":"23","author":"Ott","year":"2019","journal-title":"Trends in Cognitive Sciences"},{"issue":"4","key":"10.1016\/bs.irn.2022.10.004_bb0890","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00213-007-0856-2","article-title":"Activation of the mGlu7 receptor elicits antidepressant-like effects in mice","volume":"194","author":"Palucha","year":"2007","journal-title":"Psychopharmacology"},{"issue":"9","key":"10.1016\/bs.irn.2022.10.004_bb0895","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nm1632","article-title":"Activation of mGlu2\/3 receptors as a new approach to treat schizophrenia: A randomized phase 2 clinical trial","volume":"13","author":"Patil","year":"2007","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb0900","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0357-17.2018","article-title":"PTSD-related behavioral traits in a rat model of blast-induced mTBI are reversed by the mGluR2\/3 receptor antagonist BCI-838","volume":"5","author":"Perez-Garcia","year":"2018","journal-title":"eNeuro"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb0905","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1471-4159.2008.05426.x","article-title":"Myelin-induced microglial neurotoxicity can be controlled by microglial metabotropic glutamate receptors","volume":"106","author":"Pinteaux-Jones","year":"2008","journal-title":"Journal of Neurochemistry"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb0910","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/mp.2013.136","article-title":"Imaging glutamate in schizophrenia: Review of findings and implications for drug discovery","volume":"19","author":"Poels","year":"2014","journal-title":"Molecular Psychiatry"},{"issue":"2","key":"10.1016\/bs.irn.2022.10.004_bb0915","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1124\/jpet.105.089839","article-title":"Fenobam: A clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity","volume":"315","author":"Porter","year":"2005","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"4169","key":"10.1016\/bs.irn.2022.10.004_bb0920","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1126\/science.186.4169.1126","article-title":"Dendritic spine \"dysgenesis\" and mental retardation","volume":"186","author":"Purpura","year":"1974","journal-title":"Science"},{"issue":"1633","key":"10.1016\/bs.irn.2022.10.004_bb0925","doi-asserted-by":"crossref","first-page":"20130157","DOI":"10.1098\/rstb.2013.0157","article-title":"Synaptic competition in structural plasticity and cognitive function","volume":"369","author":"Ramiro-Cort\u00e9s","year":"2014","journal-title":"Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences"},{"issue":"4","key":"10.1016\/bs.irn.2022.10.004_bb0930","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1176\/jnp.9.4.568","article-title":"Probing striatal function in obsessive-compulsive disorder: A PET study of implicit sequence learning","volume":"9","author":"Rauch","year":"1997","journal-title":"The Journal of Neuropsychiatry and Clinical Neurosciences"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb0935","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1503\/jpn.110190","article-title":"Glutamate system, amyloid \u00df peptides and tau protein: Functional interrelationships and relevance to Alzheimer disease pathology","volume":"38","author":"Revett","year":"2013","journal-title":"Journal of Psychiatry & Neuroscience"},{"key":"10.1016\/bs.irn.2022.10.004_bb0940","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.phrs.2016.11.013","article-title":"Metabotropic glutamate receptors and neurodegenerative diseases","volume":"115","author":"Ribeiro","year":"2017","journal-title":"Pharmacological Research"},{"issue":"12","key":"10.1016\/bs.irn.2022.10.004_bb0945","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1523\/JNEUROSCI.22-12-05219.2002","article-title":"The group I metabotropic glutamate receptor mGluR5 is required for fear memory formation and long-term potentiation in the lateral amygdala","volume":"22","author":"Rodrigues","year":"2002","journal-title":"The Journal of Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb0950","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neuron.2004.09.014","article-title":"Molecular mechanisms underlying emotional learning and memory in the lateral amygdala","volume":"44","author":"Rodrigues","year":"2004","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/bs.irn.2022.10.004_bb0955","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/cne.903550310","article-title":"Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain","volume":"355","author":"Romano","year":"1995","journal-title":"The Journal of Comparative Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2022.10.004_bb0960","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0896-6273(02)00969-8","article-title":"The need to feed: Homeostatic and hedonic control of eating","volume":"36","author":"Saper","year":"2002","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/bs.irn.2022.10.004_bb0965","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1038\/sj.npp.1301669","article-title":"Expression of a GRM3 splice variant is increased in the dorsolateral prefrontal cortex of individuals carrying a schizophrenia risk SNP","volume":"33","author":"Sartorius","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/bs.irn.2022.10.004_bb0970","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1124\/mol.53.2.228","article-title":"In vitro binding characteristics of a new selective group II metabotropic glutamate receptor radioligand, [3H]LY354740, in rat brain","volume":"53","author":"Schaffhauser","year":"1998","journal-title":"Molecular Pharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb0975","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pbb.2009.12.002","article-title":"Effects of a positive allosteric modulator of mGluR5 ADX47273 on conditioned avoidance response and PCP-induced hyperlocomotion in the rat as models for schizophrenia","volume":"95","author":"Schlumberger","year":"2010","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb0980","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0022-3565(24)29296-X","article-title":"Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system","volume":"299","author":"Schoepp","year":"2001","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"5562","key":"10.1016\/bs.irn.2022.10.004_bb0985","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/261717a0","article-title":"Antipsychotic drug doses and neuroleptic\/dopamine receptors","volume":"261","author":"Seeman","year":"1976","journal-title":"Nature"},{"issue":"Pt 2","key":"10.1016\/bs.irn.2022.10.004_bb0990","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1113\/jphysiol.2003.052209","article-title":"Group II metabotropic glutamate receptor modulation of excitatory transmission in rat subthalamic nucleus","volume":"553","author":"Shen","year":"2003","journal-title":"The Journal of Physiology"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb0995","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/cne.903220110","article-title":"Distribution of the mRNA for a metabotropic glutamate receptor (mGluR1) in the central nervous system: An in situ hybridization study in adult and developing rat","volume":"322","author":"Shigemoto","year":"1992","journal-title":"The Journal of Comparative Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb1000","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0304-3940(93)90227-C","article-title":"Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain","volume":"163","author":"Shigemoto","year":"1993","journal-title":"Neuroscience Letters"},{"issue":"19","key":"10.1016\/bs.irn.2022.10.004_bb1005","doi-asserted-by":"crossref","first-page":"7503","DOI":"10.1523\/JNEUROSCI.17-19-07503.1997","article-title":"Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus","volume":"17","author":"Shigemoto","year":"1997","journal-title":"The Journal of Neuroscience"},{"issue":"3","key":"10.1016\/bs.irn.2022.10.004_bb1010","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.brainresrev.2004.04.004","article-title":"Molecular pharmacology of glutamate transporters, EAATs and VGLUTs","volume":"45","author":"Shigeri","year":"2004","journal-title":"Brain Research. Brain Research Reviews"},{"issue":"8","key":"10.1016\/bs.irn.2022.10.004_bb1015","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1111\/bph.12254","article-title":"The antipsychotic-like effects of positive allosteric modulators of metabotropic glutamate mGlu4 receptors in rodents","volume":"169","author":"S\u0142awi\u0144ska","year":"2013","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2022.10.004_bb1020","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/nn746","article-title":"Internalization of ionotropic glutamate receptors in response to mGluR activation","volume":"4","author":"Snyder","year":"2001","journal-title":"Nature Neuroscience"},{"key":"10.1016\/bs.irn.2022.10.004_bb1025","first-page":"45","article-title":"Progress toward therapeutic potential for AFQ056 in fragile X syndrome","volume":"5","author":"Sourial","year":"2013","journal-title":"Journal of Experimental Pharmacology"},{"issue":"4","key":"10.1016\/bs.irn.2022.10.004_bb1030","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1358\/dnp.2004.17.4.829052","article-title":"mGlu5 receptor antagonists: A novel class of anxiolytics?","volume":"17","author":"Spooren","year":"2004","journal-title":"Drug News & Perspectives"},{"issue":"4","key":"10.1016\/bs.irn.2022.10.004_bb1035","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3233\/JAD-201146","article-title":"Metabotropic glutamate receptors in Alzheimer's disease synaptic dysfunction: Therapeutic opportunities and Hope for the future","volume":"78","author":"Srivastava","year":"2020","journal-title":"Journal of Alzheimer's Disease"},{"issue":"52","key":"10.1016\/bs.irn.2022.10.004_bb1040","doi-asserted-by":"crossref","first-page":"18212","DOI":"10.1073\/pnas.0408278102","article-title":"N-ethylmaleimide-sensitive factor is required for the synaptic incorporation and removal of AMPA receptors during cerebellar long-term depression","volume":"101","author":"Steinberg","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1016\/bs.irn.2022.10.004_bb1045","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0306-4522(01)00305-0","article-title":"Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: Differential location relative to pre- and postsynaptic sites","volume":"106","author":"Tamaru","year":"2001","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/bs.irn.2022.10.004_bb1050","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1046\/j.1460-9568.2000.00959.x","article-title":"Gq protein alpha subunits Galphaq and Galpha11 are localized at postsynaptic extra-junctional membrane of cerebellar Purkinje cells and hippocampal pyramidal cells","volume":"12","author":"Tanaka","year":"2000","journal-title":"The European Journal of Neuroscience"},{"issue":"6","key":"10.1016\/bs.irn.2022.10.004_bb1055","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1523\/JNEUROSCI.23-06-02150.2003","article-title":"Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity","volume":"23","author":"Taylor","year":"2003","journal-title":"The Journal of Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb1060","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/(SICI)1096-9861(19980105)390:1<5::AID-CNE2>3.0.CO;2-6","article-title":"Immunohistochemical localization of metabotropic glutamate receptors mGluR1a and mGluR2\/3 in the rat basal ganglia","volume":"390","author":"Testa","year":"1998","journal-title":"The Journal of Comparative Neurology"},{"issue":"5 Pt 2","key":"10.1016\/bs.irn.2022.10.004_bb1065","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1523\/JNEUROSCI.14-05-03005.1994","article-title":"Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat","volume":"14","author":"Testa","year":"1994","journal-title":"The Journal of Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb1070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13024-018-0293-1","article-title":"Functional alterations of myeloid cells during the course of Alzheimer's disease","volume":"13","author":"Thome","year":"2018","journal-title":"Molecular Neurodegeneration"},{"issue":"1\u20133","key":"10.1016\/bs.irn.2022.10.004_bb1075","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.schres.2006.07.008","article-title":"No association between the metabotropic glutamate receptor type 3 gene (GRM3) and schizophrenia in a Japanese population","volume":"88","author":"Tochigi","year":"2006","journal-title":"Schizophrenia Research"},{"issue":"24","key":"10.1016\/bs.irn.2022.10.004_bb1080","doi-asserted-by":"crossref","first-page":"14374","DOI":"10.1073\/pnas.2336265100","article-title":"The fragile X mental retardation protein is required for type-I metabotropic glutamate receptor-dependent translation of PSD-95","volume":"100","author":"Todd","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1016\/bs.irn.2022.10.004_bb1085","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1124\/jpet.104.080481","article-title":"Group III metabotropic glutamate-receptor-mediated modulation of excitatory transmission in rodent substantia nigra pars compacta dopamine neurons","volume":"313","author":"Valenti","year":"2005","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb1090","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/cne.903620108","article-title":"Metabotropic glutamate receptor mGluR5 subcellular distribution and developmental expression in hypothalamus","volume":"362","author":"van den Pol","year":"1995","journal-title":"The Journal of Comparative Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2022.10.004_bb1095","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1152\/physrev.00007.2013","article-title":"Mechanisms of glutamate transport","volume":"93","author":"Vandenberg","year":"2013","journal-title":"Physiological Reviews"},{"issue":"12","key":"10.1016\/bs.irn.2022.10.004_bb1100","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1369\/0022155411425386","article-title":"mGluR6 transcripts in non-neuronal tissues","volume":"59","author":"Vardi","year":"2011","journal-title":"The Journal of Histochemistry and Cytochemistry"},{"key":"10.1016\/bs.irn.2022.10.004_bb1105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuint.2016.11.009","article-title":"Targeting the norepinephrinergic system in Parkinson's disease and related disorders: The locus coeruleus story","volume":"102","author":"Vermeiren","year":"2017","journal-title":"Neurochemistry International"},{"issue":"7","key":"10.1016\/bs.irn.2022.10.004_bb1110","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1111\/j.1460-9568.2005.04362.x","article-title":"Neuroprotective effects of metabotropic glutamate receptor ligands in a 6-hydroxydopamine rodent model of Parkinson's disease","volume":"22","author":"Vernon","year":"2005","journal-title":"The European Journal of Neuroscience"},{"issue":"12","key":"10.1016\/bs.irn.2022.10.004_bb1115","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1176\/appi.ajp.2010.10030318","article-title":"Alterations in metabotropic glutamate receptor 1\u03b1 and regulator of G protein signaling 4 in the prefrontal cortex in schizophrenia","volume":"167","author":"Volk","year":"2010","journal-title":"The American Journal of Psychiatry"},{"issue":"6","key":"10.1016\/bs.irn.2022.10.004_bb1120","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1037\/0735-7044.116.6.1075","article-title":"Group II metabotropic glutamate receptors within the amygdala regulate fear as assessed with potentiated startle in rats","volume":"116","author":"Walker","year":"2002","journal-title":"Behavioral Neuroscience"},{"issue":"13","key":"10.1016\/bs.irn.2022.10.004_bb1125","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1523\/JNEUROSCI.1633-03.2004","volume":"24","author":"Wang","year":"2004","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2022.10.004_bb1130","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijdevneu.2015.01.003","article-title":"Sexual differences in long-term effects of prenatal chronic mild stress on anxiety-like behavior and stress-induced regional glutamate receptor expression in rat offspring","volume":"41","author":"Wang","year":"2015","journal-title":"International Journal of Developmental Neuroscience"},{"issue":"4","key":"10.1016\/bs.irn.2022.10.004_bb1135","article-title":"Hippocampal protein kinase D1 is necessary for DHPG-induced learning and memory impairments in rats","volume":"13","author":"Wang","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/bs.irn.2022.10.004_bb1140","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s41380-018-0234-y","article-title":"mGluR5 hypofunction is integral to glutamatergic dysregulation in schizophrenia","volume":"25","author":"Wang","year":"2020","journal-title":"Molecular Psychiatry"},{"issue":"50","key":"10.1016\/bs.irn.2022.10.004_bb1145","doi-asserted-by":"crossref","first-page":"17504","DOI":"10.1073\/pnas.0407533101","article-title":"Fragile X mental retardation protein is necessary for neurotransmitter-activated protein translation at synapses","volume":"101","author":"Weiler","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.irn.2022.10.004_bb1150","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pharmthera.2015.10.007","article-title":"Metabotropic glutamate receptors as targets for new antipsychotic drugs: Historical perspective and critical comparative assessment","volume":"157","author":"Wieronska","year":"2016","journal-title":"Pharmacology & Therapeutics"},{"issue":"1","key":"10.1016\/bs.irn.2022.10.004_bb1155","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00213-014-3657-4","article-title":"The antipsychotic-like effects in rodents of the positive allosteric modulator Lu AF21934 involve 5-HT1A receptor signaling: Mechanistic studies","volume":"232","author":"Wieronska","year":"2015","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/bs.irn.2022.10.004_bb1160","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1152\/jn.00180.2004","article-title":"Group I metabotropic glutamate receptor activation produces a direct excitation of identified septohippocampal cholinergic neurons","volume":"92","author":"Wu","year":"2004","journal-title":"Journal of Neurophysiology"},{"key":"10.1016\/bs.irn.2022.10.004_bb1165","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.freeradbiomed.2015.09.017","article-title":"Blockade of metabotropic glutamate receptor 5 protects against DNA damage in a rotenone-induced Parkinson's disease model","volume":"89","author":"Xia","year":"2015","journal-title":"Free Radical Biology & Medicine"},{"issue":"677","key":"10.1016\/bs.irn.2022.10.004_bb1170","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abd2319","article-title":"Input-specific regulation of glutamatergic synaptic transmission in the medial prefrontal cortex by mGlu","volume":"14","author":"Xiang","year":"2021","journal-title":"Science Signaling"},{"issue":"2","key":"10.1016\/bs.irn.2022.10.004_bb1175","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1523\/JNEUROSCI.2289-15.2016","article-title":"Dynamic changes in striatal mGluR1 but not mGluR5 during pathological progression of Parkinson's disease in human alpha-synuclein A53T transgenic rats: A multi-PET imaging study","volume":"36","author":"Yamasaki","year":"2016","journal-title":"The Journal of Neuroscience"},{"issue":"11","key":"10.1016\/bs.irn.2022.10.004_bb1180","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1038\/s41380-018-0206-2","article-title":"Activation of the mGlu","volume":"25","author":"Yohn","year":"2020","journal-title":"Molecular Psychiatry"},{"issue":"3","key":"10.1016\/bs.irn.2022.10.004_bb1185","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/npp.2017.177","article-title":"Effect of the mGluR5-NAM basimglurant on behavior in adolescents and adults with fragile X syndrome in a randomized, double-blind, placebo-controlled trial: FragXis phase 2 results","volume":"43","author":"Youssef","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/bs.irn.2022.10.004_bb1190","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0092-8674(01)00589-X","article-title":"Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function","volume":"107","author":"Zhang","year":"2001","journal-title":"Cell"},{"issue":"2","key":"10.1016\/bs.irn.2022.10.004_bb1195","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s12640-009-9068-3","article-title":"Activation of group III metabotropic glutamate receptor reduces intracellular calcium in beta-amyloid peptide [31-35]-treated cortical neurons","volume":"16","author":"Zhao","year":"2009","journal-title":"Neurotoxicity Research"}],"container-title":["International Review of Neurobiology","Metabotropic Glutamate Receptors in Psychiatric and Neurological Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774222001143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774222001143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T13:11:37Z","timestamp":1753708297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774222001143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9780323993944"],"references-count":238,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2022.10.004","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}